NEO vs CDNA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 02, 2026
NEO
CDNA
Investment Advisor Scores
CDNA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NEO | CDNA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 222.2222 | 94.3396 | CDNA |
| PEG Ratio | 2.0871 | -0.12 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 11.2% | 39.0% | CDNA |
| Earnings Growth | 130.6% | 0.0% | NEO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 49.2/100 | 44.7/100 | NEO |
| Profit Margin | -6.8% | -2.0% | CDNA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NEO
MarkupPrice above SMA50, rising 50-day trend (22.4% over 20 days), RSI 61
CDNA
MarkupPrice above SMA50, rising 50-day trend (23.4% over 20 days), RSI 77
Fundamentals Snapshot
| Metric | NEO | CDNA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 45.2 | 38.5 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.4% |
| Gross Margin | 0.4% | 0.7% |
| Operating Margin | 0.0% | 0.0% |
| EPS | -0.40 | -0.17 |
| Dividend Yield | — | — |